The novel approach of this peptide represents a significant advance in the handling of diabetes mellitus type 2. Distinct from existing medications, tirzepatide affects dual pathways – GLP-1 and GIP – providing https://tirzepatidepeptide402539.livebloggs.com/48807759/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment